How effective are antidepressants for depression over the long term? A critical review of relapse prevention trials and the issue of withdrawal confounding
Open accessThe DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Abstract
The aim of this article is to discuss the validity of relapse prevention trials and the issue of withdrawal confounding in these trials. Recommendations for long-term antidepressant treatment are based almost exclusively on discontinuation trials. In these relapse prevention trials, participants with remitted depression are randomised either to have the antidepressant abruptly discontinued and replaced by inert placebo or to continue active treatment. The drug–placebo difference in relapse rates at the end of the maintenance phase is then interpreted as a prophylactic drug effect. These trials consistently produce remarkable benefits for maintenance treatment. However, the internal validity of this trial protocol is compromised, as research has shown that abruptly stopping antidepressants can cause severe withdrawal reactions that lead to (or manifest as) depression relapses. That is, there is substantial withdrawal confounding in discontinuation trials, which renders their findings uninterpretable. It is not clear to what degree the drug–placebo separation in relapse prevention (discontinuation) trials is due to withdrawal reactions, but various estimations suggest that it is presumably the majority. A review of findings based on other methodologies, including real-world long-term effectiveness trials like STAR*D and various naturalistic cohort studies, do not indicate that antidepressants have considerable prophylactic effects. As absence of evidence does not imply evidence of absence, no definitive conclusions can be drawn from the literature. To enable a thorough risk–benefit evaluation, real-world effectiveness trials should not only focus on relapse prevention, but also assess antidepressants’ long-term effects on social functioning and quality of life. Thus far, reliable long-term data on these outcome domains are lacking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“although none of the trials on which this conclusion was based measured withdrawal effects (Cohen 2019;Hengartner 2020;Recalt 2019)”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Hengartner 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Research suggests this could pertain to most relapses (El-Mallakh 2012; Greenhouse 1991; Hengartner 2020; Recalt 2019; Rosenbaum 1988).”
From Approaches for discontinuation versus continuation of long-term antidepressant use for depressive and anxiety disorders in adults (2021) · cites this paper as Hengartner 2020
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“while relapse has been detected in 41% of such patients (with this value undoubtedly inflated by misdiagnosis of withdrawal symptoms),20”
From The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition (2020) · cites this paper as [20]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has also been noted in several reviews of antidepressant withdrawal symptoms that such reactions can be mistaken for relapse of the underlying condition for which the antidepressant was originally prescribed,18–20”
The cited source says what the claim attributes to it.
In the citing paper
“Minimisation of these methodological flaws has led to antidepressants being presented as more effective than is warranted by existing data.20,38,42,43”
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Statistics notes: Absence of evidence is not evidence of absence
Altman, D. G., & Bland, J. M. (1995) · BMJ · doi:10.1136/bmj.311.7003.485 · Cited by 1,946
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,520
Lund, C., Brooke-Sumner, C., Baingana, F., Baron, E. C., Breuer, E., Chandra, P., Haushofer, J., Herrman, H., Jordans, M., Kieling, C., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30060-9 · Cited by 1,147
Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945
Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016) · Psychotherapy and Psychosomatics · doi:10.1159/000447034 · Cited by 650
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial
Rosenbaum, J. F., Fava, M., Hoog, S. L., Ascroft, R. C., & Krebs, W. B. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00126-7 · Cited by 574
Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000370338 · Cited by 436
Influences on antidepressant prescribing trends in the UK: 1995–2011
Mars, B., Heron, J., Kessler, D., Davies, N. M., Martin, R. M., Thomas, K. H., & Gunnell, D. (2017) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-016-1306-4 · Cited by 419
Melfi, C. A., Chawla, A. J., Croghan, T. W., Hanna, M. P., Kennedy, S., & Sredl, K. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.12.1128 · Cited by 409
Depression in adults: recognition and management
(2017) · Clinical Pharmacist · doi:10.1211/cp.2017.20202439 · Cited by 393
Davies, J., & Read, J. (2019) · Addictive Behaviors · doi:10.1016/j.addbeh.2018.08.027 · Cited by 387
Efficacy and effectiveness of antidepressants: current status of research
Pigott, H. E., Leventhal, A. M., Alter, G. S., & Boren, J. J. (2010) · Psychotherapy and Psychosomatics · doi:10.1159/000318293 · Cited by 347
Antidepressant discontinuation reactions: Are preventable and simple to treat
Haddad, P., Lejoyeux, M., & Young, A. (1998) · BMJ · doi:10.1136/bmj.316.7138.1105 · Cited by 286
Detke, M. J., Wiltse, C. G., Mallinckrodt, C. H., McNamara, R. K., Demitrack, M. A., & Bitter, I. (2004) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.01.002 · Cited by 282
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Mojtabai, R., & Olfson, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08443 · Cited by 247
Interface between authorship, industry and science in the domain of therapeutics
Healy, D., & Cattell, D. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.183.1.22 · Cited by 218
Bauer, M., Severus, E., Köhler, S., Whybrow, P. C., Angst, J., Möller, H.-J., & on behalf of the Wfsbp Task Force on Treatment Guidelines for Unipolar Depressive Disorders (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2014.1001786 · Cited by 199
Repeated Job Strain and the Risk of Depression: Longitudinal Analyses From the Whitehall II Study
Stansfeld, S. A., Shipley, M. J., Head, J., & Fuhrer, R. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300589 · Cited by 187
Michelson, D., Fava, M., Amsterdam, J., Apter, J., Londborg, P., Tamura, R., & Tepner, R. G. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.176.4.363 · Cited by 181
Evidence for clinical progression of unipolar and bipolar disorders
Kessing, L. V., & Andersen, P. K. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12667 · Cited by 179
Steinert, C., Hofmann, M., Kruse, J., & Leichsenring, F. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.10.017 · Cited by 178
Hansen, R., Gaynes, B., Thieda, P., Gartlehner, G., Deveaugh-Geiss, A., Krebs, E., & Lohr, K. (2008) · Psychiatric Services · doi:10.1176/ps.2008.59.10.1121 · Cited by 172
New Classification of Selective Serotonin Reuptake Inhibitor Withdrawal
Chouinard, G., & Chouinard, V.-A. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000371865 · Cited by 164
Montgomery, S. A., Rasmussen, J. G. C., & Tanghøj, P. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300830-00008 · Cited by 163
The mechanisms of tolerance in antidepressant action
Fava, G. A., & Offidani, E. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.07.026 · Cited by 158
Munkholm, K., Paludan-Müller, A. S., & Boesen, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024886 · Cited by 151
Antipsychotics in the Treatment of Delirium: A Systematic Review
Seitz, D. P., Gill, S. S., & van Zyl, L. T. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0102 · Cited by 150
Discontinuing antidepressant treatment in major depression.
Viguera, A. C., Baldessarini, R. J., & Friedberg, J. (1998) · Harvard Review of Psychiatry · doi:10.3109/10673229809003578 · Cited by 145
Why antidepressants are not antidepressants: STEP‐BD, STAR*D, and the return of neurotic depression
Nassir Ghaemi, S. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00639.x · Cited by 144
Review: problems associated with long-term treatment with selective serotonin reuptake inhibitors
Moret, C., Isaac, M., & Briley, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108093582 · Cited by 135
Kaymaz, N., van Os, J., Loonen, A. J. M., & Nolan, W. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0910 · Cited by 135
Illness risk following rapid versus gradual discontinuation of antidepressants
Baldessarini, R. J., Tondo, L., Ghiani, C., & Lepri, B. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09060880 · Cited by 123
Continuation and Maintenance Use of Antidepressants in Recurrent Depression
Bockting, C. L. H., ten Doesschate, M. C., Spijker, J., Spinhoven, P., Koeter, M. W. J., & Schene, A. H. (2008) · Psychotherapy and Psychosomatics · doi:10.1159/000110056 · Cited by 121
Rush, A. J., Trivedi, M. H., Carmody, T. J., Biggs, M. M., Shores‐Wilson, K., Ibrahim, H. M., & Crismon, M. L. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.04.005 · Cited by 113
Borges, S., Chen, Y.-F., Laughren, T. P., Temple, R., Patel, H. D., David, P. A., Mathis, M., Unger, E., Yang, P., & Khin, N. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08722 · Cited by 109
Recognising and managing antidepressant discontinuation symptoms
Haddad, P. M., & Anderson, I. M. (2007) · Advances in Psychiatric Treatment · doi:10.1192/apt.bp.105.001966 · Cited by 109
Ebrahim, S., Bance, S., Athale, A., Malachowski, C., & Ioannidis, J. P. A. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.08.021 · Cited by 107
Andrews, P. W., Kornstein, S. G., Halberstadt, L. J., Gardner, C. O., & Neale, M. C. (2011) · Frontiers in Psychology · doi:10.3389/fpsyg.2011.00159 · Cited by 107
Marsden, J., White, M., Annand, F., Burkinshaw, P., Carville, S., Eastwood, B., Kelleher, M., Knight, J., O'Connor, R., Tran, A., et al. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30331-1 · Cited by 106
Reviewing long-term antidepressants can reduce drug burden: a prospective observational cohort study
Johnson, C. F., Macdonald, H. J., Atkinson, P., Buchanan, A. I., Downes, N., & Dougall, N. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x658304 · Cited by 105
Nielsen, M., Hansen, E. H., & Gøtzsche, P. C. (2012) · Addiction · doi:10.1111/j.1360-0443.2011.03686.x · Cited by 103
Clinical trials and drug promotion: Selective reporting of study 329
Jureidini, J. N., McHenry, L. B., & Mansfield, P. R. (2008) · International Journal of Risk and Safety in Medicine · doi:10.3233/jrs-2008-0426 · Cited by 98
de Vries, Y. A., Roest, A. M., de Jonge, P., Cuijpers, P., Munafò, M. R., & Bastiaansen, J. A. (2018) · Psychological Medicine · doi:10.1017/s0033291718001873 · Cited by 98
Rational Use of Antidepressant Drugs
Fava, G. A. (2014) · Psychotherapy and Psychosomatics · doi:10.1159/000362803 · Cited by 95
Hengartner, M. P., & Plöderl, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00517 · Cited by 93
Self-citationMethodologic issues in maintenance therapy clinical trials
Greenhouse, J. B. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810280029004 · Cited by 89
Lerner, A., & Klein, M. (2019) · Brain Communications · doi:10.1093/braincomms/fcz025 · Cited by 89
Discontinuation symptoms: comparison of brief interruption in fluoxetine and paroxetine treatment
Judge, R., Parry, M. G., Quail, D., & Jacobson, J. G. (2002) · International Clinical Psychopharmacology · doi:10.1097/00004850-200209000-00002 · Cited by 87
Leykin, Y., Amsterdam, J. D., DeRubeis, R. J., Gallop, R., Shelton, R. C., & Hollon, S. D. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.2.267 · Cited by 82
Tardive dysphoria: The role of long term antidepressant use in-inducing chronic depression
El‐Mallakh, R. S., Gao, Y., & Roberts, R. J. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.01.020 · Cited by 81
Fornaro, M., Anastasia, A., Novello, S., Fusco, A., Pariano, R., De Berardis, D., Solmi, M., Veronese, N., Stubbs, B., Vieta, E., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.10.025 · Cited by 80
KESSING, L. V., VIBE HANSEN, H., DEMYTTENAERE, K., & BECH, P. (2005) · Psychological Medicine · doi:10.1017/s0033291705004605 · Cited by 78
Deshauer, D., Moher, D., Fergusson, D., Moher, E., Sampson, M., & Grimshaw, J. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.071068 · Cited by 78
ten Have, M., Penninx, B. W. J. H., Tuithof, M., van Dorsselaer, S., Kleinjan, M., Spijker, J., & de Graaf, R. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12753 · Cited by 76
A systematic review of long-term studies of drug treated and non-drug treated depression
Hughes, S., & Cohen, D. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.027 · Cited by 71
Understanding and Managing Withdrawal Syndromes After Discontinuation of Antidepressant Drugs
Fava, G. A., & Cosci, F. (2019) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19com12794 · Cited by 69
Claxton, A. J., Li, Z., & McKendrick, J. (2000) · British Journal of Psychiatry · doi:10.1192/bjp.177.2.163 · Cited by 68
Huijbregts, K. M., Hoogendoorn, A., Slottje, P., van Balkom, A. J. L. M., & Batelaan, N. M. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000480456 · Cited by 68
Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020) · PLOS ONE · doi:10.1371/journal.pone.0229381 · Cited by 66
Self-citationAre antidepressants overprescribed? Yes
Spence, D. (2013) · BMJ · doi:10.1136/bmj.f191 · Cited by 59
Why is it so difficult to stop psychiatric drug treatment?
Moncrieff, J. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.03.009 · Cited by 59
SSRI and SNRI withdrawal symptoms reported on an internet forum
Stockmann, T., Odegbaro, D., Timimi, S., & Moncrieff, J. (2018) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-180018 · Cited by 54
Harvey, S. B., Sellahewa, D. A., Wang, M., Milligan-Saville, J. S., Bryan, B. T., Henderson, M., Hatch, S. L., & Mykletun, A. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30137-8 · Cited by 53
Hengartner, M. P. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00275 · Cited by 52
Self-citationAntidepressant withdrawal – the tide is finally turning
Hengartner, M. P., Davies, J., & Read, J. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000465 · Cited by 48
Self-citationGardarsdottir, H., Egberts, T. C., Stolker, J. J., & Heerdink, E. R. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp142 · Cited by 47
Prasad, V. K., & Berger, V. W. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.05.006 · Cited by 45
Belaise, C., Gatti, A., Chouinard, V.-A., & Chouinard, G. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000341178 · Cited by 45
Financial conflicts of interest in psychiatry.
Fava, G. A. (2007) · PubMed · Cited by 45
Verhaak, P. F. M., de Beurs, D., & Spreeuwenberg, P. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-024051 · Cited by 45
Limitations of contemporary antidepressants: tolerability.
Papakostas, G. I. (2007) · PubMed · Cited by 44
Clinical guidelines on antidepressant withdrawal urgently need updating
Davies, J., Read, J., Hengartner, M. P., Cosci, F., Fava, G., Chouinard, G., van Os, J., Nardi, A., Gøtzsche, P., Groot, P., et al. (2019) · BMJ · doi:10.1136/bmj.l2238 · Cited by 44
Self-citationEffectiveness of antidepressants
McCormack, J., & Korownyk, C. (2018) · BMJ · doi:10.1136/bmj.k1073 · Cited by 43
Hengartner, M. P., Angst, J., & Rössler, W. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488802 · Cited by 42
Self-citationAmsterdam, J. D., Williams, D., Michelson, D., Adler, L. A., Dunner, D. L., Nierenberg, A. A., Reimherr, F. W., & Schatzberg, A. F. (2009) · Neuropsychobiology · doi:10.1159/000226611 · Cited by 39
Franks, M., Macritchie, K., Mahmood, T., & Young, A. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107085238 · Cited by 39
Récalt, A. M., & Cohen, D. (2019) · Psychotherapy and Psychosomatics · doi:10.1159/000496734 · Cited by 38
Read, J. (2020) · Addictive Behaviors · doi:10.1016/j.addbeh.2019.106157 · Cited by 37
Studies of Long-Term Use of Antidepressants: How Should the Data from Them be Interpreted?
El-Mallakh, R. S., & Briscoe, B. (2012) · CNS Drugs · doi:10.2165/11599450-000000000-00000 · Cited by 36
How many of 1829 antidepressant users report withdrawal effects or addiction?
Read, J., Cartwright, C., & Gibson, K. (2018) · International Journal of Mental Health Nursing · doi:10.1111/inm.12488 · Cited by 36
Attacks on antidepressants: signs of deep-seated stigma?
Nutt, D. J., Goodwin, G. M., Bhugra, D., Fazel, S., & Lawrie, S. M. (2014) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)70232-9 · Cited by 33
Selective serotonin reuptake inhibitor ‘discontinuation syndrome’ or withdrawal
Massabki, I., & Abi-Jaoude, E. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2019.269 · Cited by 33
Gardarsdottir, H., van Geffen, E. C. G., Stolker, J. J., Egberts, T. C. G., & Heerdink, E. R. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31819302b1 · Cited by 27
Discontinuing psychotropic drug treatment
Tondo, L., & Baldessarini, R. J. (2020) · BJPsych Open · doi:10.1192/bjo.2020.6 · Cited by 27
Depression and Antidepressants: A Nordic Perspective
Vilhelmsson, A. (2013) · Frontiers in Public Health · doi:10.3389/fpubh.2013.00030 · Cited by 26
Verdoux, H., Cougnard‐Grégoire, A., Thiébaut, A. C. M., & Tournier, M. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1271686 · Cited by 26
Ghaemi, S. N., & Selker, H. P. (2017) · Journal of Clinical and Translational Science · doi:10.1017/cts.2017.2 · Cited by 24
The antidepressant standoff: Why it continues and how to resolve it
Ormel, J., Spinhoven, P., de Vries, Y. A., Cramer, A. O. J., Siegle, G. J., Bockting, C. L. H., & Hollon, S. D. (2020) · Psychological Medicine · doi:10.1017/s0033291719003295 · Cited by 22
Are antidepressants overprescribed? No
Reid, I. C. (2013) · BMJ · doi:10.1136/bmj.f190 · Cited by 22
Impact of Study Design on the Results of Continuation Studies of Antidepressants
Zimmerman, M., Posternak, M. A., & Ruggero, C. J. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31803308e1 · Cited by 20
Outcome of mood disorders before psychopharmacology: A systematic review
Mulder, R., & Frampton, C. M. (2013) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867413514490 · Cited by 20
Long‐term antidepressant treatment: time for a review?
Kendrick, T. (2015) · Prescriber · doi:10.1002/psb.1389 · Cited by 13
Hengartner, M. P. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.23 · Cited by 13
Self-citationAntidepressants; what’s the beef?
Goodwin, G. M., & Nutt, D. J. (2019) · Acta Neuropsychiatrica · doi:10.1017/neu.2019.4 · Cited by 10
Psychiatric drugs as agents of trauma
Whitfield, C. L. (2010) · International Journal of Risk & Safety in Medicine · doi:10.3233/jrs-2010-0508 · Cited by 8
Perlis, R. H. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18040399 · Cited by 8
What it was like to stop an antidepressant
Stockmann, T. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319884834 · Cited by 6
Treatment-induced stress syndromes
Healy, D. (2010) · Medical Hypotheses · doi:10.1016/j.mehy.2010.01.038 · Cited by 5
Risks in Discontinuation Trials With Antidepressants
Baldessarini, R. J. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14lr09255 · Cited by 4
Research works printed but not linked: 2
- Whitaker R Anatomy of an epidemic. New York, NY: Crown Publishers, 2010.
- Amsterdam JD McHenry LB The paroxetine 352 bipolar study revisited: deconstruction of corporate and academic misconduct. J Sci Pract Integr 2019; 1: 1– 12.
Cited by
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis
Fountoulakis, K. N., Saitis, A., & Schatzberg, A. F. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20240515 · Cited by 90
Van Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90
Fava, G. A. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320970325 · Cited by 84
Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967183 · Cited by 77
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
Horowitz, M. A., Framer, A., Hengartner, M. P., Sørensen, A., & Taylor, D. (2023) · CNS Drugs · doi:10.1007/s40263-022-00960-y · Cited by 76
“Severe withdrawal effects can lead to misdiagnosis of other medical conditions or a misdiagnosis of relapse [8, 9], presentations to the emergency department [10] and suicide attempts [11].”
BackgroundSelf-citation
Metadata
- Authors
- Hengartner, M. P.
- Affiliations
- University of Zurich (CH)
- Corresponding author
- Hengartner, Michael P.
- Venue
- Therapeutic Advances in Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 10
- Pages
- 2045125320921694-2045125320921694
- ISSN
- 2045-1253 (ISSN-L)
- 2045-1261
- PMC
- PMC7225779
- OpenAlex
- W3023952186
- Semantic Scholar
- 32e937d741f68bb4ff5c186ae3e72fc7eaf87b19
- Cited by
- 72
- References
- 102
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 13 · 2023: 9 · 2022: 8 · 2021: 14 · 2020: 6
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Therapeutic Advances in Psychopharmacology (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Zürcher Hochschule für Angewandte Wissenschaften digital collection (Zurich University of Applied Sciences) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- ZHAW Digital Collection
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- antidepressants, depression, relapse prevention, maintenance therapy, preventive effect, STAR*D, long-term effectiveness, social functioning, quality of life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.